Results 71 to 80 of about 145,462 (345)

Circular RNA hsa_circ_0000034 promotes the progression of retinoblastoma via sponging microRNA-361-3p

open access: yesBioengineered, 2020
Retinoblastoma is the commonest eye cancer occurring in the pediatric population. Circular RNAs (circRNAs) are essential regulators of tumorigenesis and development.
Zhe Sun, Ai Zhang, Mingyu Hou, T. Jiang
semanticscholar   +1 more source

Senescent cells: A therapeutic target for osteoporosis

open access: yesCell Proliferation, Volume 55, Issue 12, December 2022., 2022
Bone is a metabolically active tissue involved in physiological processes of locomotion, support and protection of soft tissues, calcium and phosphate storage, and harbouring of bone marrow. Bone is constituted by various types of cells undergoing continuous remodelling.
Tiantian Wang, Shishu Huang, Chengqi He
wiley   +1 more source

Sclero-conjunctival ischaemia secondary to intra-arterial chemotherapy for retinoblastoma

open access: yesAmerican Journal of Ophthalmology Case Reports, 2020
Purpose: Intra-arterial chemotherapy (IAC), delivered directly to the globe via the internal carotid artery is now an established treatment for retinoblastoma.
Lisa McAnena   +5 more
doaj  

Retinoblastoma: A spectrum of manifestations in three cases on B-scan

open access: yesIndian Journal of Radiology and Imaging, 2007
Retinoblastoma is a primary intraocular neoplasm of childhood, presenting with leukocoria.We present a spectrum of three cases. First two cases are of bilateral retinoblastoma and last case is a retinoblastoma of right eye.
V. D. Aironi   +3 more
doaj   +1 more source

Inhibitory activity of bevacizumab to differentiation of retinoblastoma cells. [PDF]

open access: yesPLoS ONE, 2012
Vascular endothelial growth factor (VEGF) is a major regulator in retinal and choroidal angiogenesis, which are common causes of blindness in all age groups.
Jang Won Heo   +6 more
doaj   +1 more source

Retinoblastoma in Calabar Nigeria: An 18-Month Retrospective Review of Clinical Presentation at a Tertiary Eye Center

open access: yesNigerian Journal of Medicine, 2022
Background: Retinoblastoma, although rare, is the most frequently occurring primary intraocular tumor of childhood. While a cure is often achieved where appropriate treatment is instituted early in the disease, late presentation often leads to ...
Elizabeth Dennis Nkanga   +7 more
doaj   +1 more source

DILEMA DALAM MANAJEMEN RETINOBLASTOMA

open access: yesMajalah Kedokteran Andalas, 2014
Abstrak:Retinoblastoma merupakan keganasan intraokular tersering pada anak-anak. Deteksi dini memegang peranan penting dalam manajemen retinoblastoma karena sangat mempengaruhi prognosa.
Ardizal Rahman
doaj   +1 more source

Therapeutic target discovery using Boolean network attractors: avoiding pathological phenotypes [PDF]

open access: yesComptes Rendus Biologies, Elsevier, 2014, 337 (12), pp.661-678., 2014
Target identification, one of the steps of drug discovery, aims at identifying biomolecules whose function should be therapeutically altered in order to cure the considered pathology. This work proposes an algorithm for in silico target identification using Boolean network attractors.
arxiv   +1 more source

Sensory Compensation in Children Following Vision Loss after Trauma and Disease [PDF]

open access: yes, 2015
Sensory compensation or sensory substitution occurs when a sense organ, such as the eye, is lost due to trauma or disease. Individuals often experience phantom limb sensation or pain but research increasingly points towards some individuals developing a ...
Chinnery, H., Thompson, S.
core   +1 more source

Non-invasive diagnosis of retinoblastoma using cell-free DNA from aqueous humour

open access: yesBritish Journal of Ophthalmology, 2019
Retinoblastoma is the most common eye malignancy in childhood caused by mutations in the RB1 gene. Both alleles of the RB1 gene must be mutated for tumour development. The initial RB1 mutation may be constitutional germline or somatic (originating in one
A. Gerrish   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy